866-997-4948 (US-Canada Toll Free)

Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency

Published Date : 2013-10-11

Category :

Biotechnology

No. of Pages : 97

Product Synopsis

Transcriptomics refer to the structural and functional aspects of complete set of transcripts present in an individual or group of cells. The demand for transcriptomics research is increasing majorly due to consistent technological upgradations in several techniques (such as polymerase chain reaction (PCR), ribonucleic acid (RNA) sequencing and microarrays, etc.) employed for transcriptome analysis. The other notable factors include increased research in the field of “omics” technologies followed by heightened preference for personalized medicine which further propel transcriptomics market growth. The major technologies employed for transcriptome analysis comprises microarrays, PCR, gene regulation studies and next generation sequencing technologies. Transcriptomics... Read More

Table Of Content

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Potential of Transcriptomics Technologies
3.1.2 Future Scenario of Transcriptomics
3.1.3 Market Dynamics
3.2 Market Drivers
3.2.1 Technological Advancements
3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)
3.2.3 Increasing Research and Development Investments
3.2.4 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Lack Of Efficient Data Analysis Tools
3.3.2 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Focus on Development of Bioinformatics Tools and Services
3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

Chapter 4 Global Transcriptomics Technologies Market, By Technology
4.1 Introduction
4.2 Microarrays
4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.2 Polymerase Chain Reaction (PCR)
4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.3 Gene Regulation Technologies (RNA Interference Technology)
4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.4 Next Generation Sequencing (NGS)
4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 5 Global Transcriptomics Technologies Market, By Application
5.1 Overview
5.2 Clinical Diagnostics
5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.3 Drug Discovery And Research
5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)
5.4 Bioinformatics
5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.5 Comparative Transcriptome Studies
5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 6 Global Transcriptomics Technologies Market, By Geography
6.1 Overview
6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)
6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)
6.2 North America
6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.5 Rest of the World (Row)
6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 7 Competitive Landscape
7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

Chapter 8 Recommendations
8.1 Collaboration with Academic and Research Institutes
8.2 Focus on Imparting Education about Genomic Medicine

Chapter 9 Company Profiles
9.1 Affymetrix, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Agilent Technologies, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Business Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Danaher Corporation
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Life Technologies Corporation
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 LC Sciences, LLC
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Sigma-Aldrich Corporation
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

List of Tables


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)
TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)
TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,  2011 – 2019(USD Million)

List of Figures

FIG. 1 Central Dogma : Transcriptomics Technologies Market
FIG. 2 Transcriptomics Technologies: Market Segmentation
FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)
FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography
FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)
FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)
FIG. 20 Affymetrix, Inc., Annual Revenue:  2010 – 2012 (USD Million)
FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)
FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Lubricating Oil Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018

    By - Transparency

    Continuous developments in the automobile, machine, and transportation industries are driving the lubricating oil market extensively. Driven by relative industries, the lubricating oil industry is emerging as one of the top petroleum and chemical industries all over the globe. Lubricating oil find numerous applications in various industries. Changing lifestyles and the growing need of comfort in each and every aspect of life is giving rise to the invention of various machines, thus indirectly driving the market for lubricating oil. The automobile industry is a major...

  • Ischemic Cardiomyopathy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

    By - Transparency

    Ischemic cardiomyopathy is the disease condition that occurs when the main heart muscle gets enlarged and dilated due to weakening of heart muscles. This condition leads to either heart attack or coronary disease leading to narrowing of the arteries. These narrowed arteries inhibit the heart’s ability to pump blood and sometimes lead to heart failure. The clinical symptoms of ischemic cardiomyopathy includes shortness of breath, dizziness, extreme fatigue, chest pain and pressure, weight gain, heart palpitations, swelling in legs, insomnia and cough or congestion in lungs. Ischemic...

  • Psychotherapeutic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Psychotherapeutic drugs market is comprised of drugs which are used to treat mental illnesses such as confused thinking, extreme mood swings, long lasting depression, social withdrawal and suicidal thought. Commonly found mental disorders are schizophrenia, bipolar disorder, anxiety and depression. Schizophrenia is a mental disease associated with hearing voices, unorganized speech and broken thoughts. Depression is a common disorder characterized by lack of confidence, pleasure and interest. The global Psychotherapeutic Drugs Market is segmented on the basis of various...